FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Biologics

FDA Broadens Covid Vaccine Probe to Include Adult Deaths

FDA opens a broad investigation into reports of deaths in adults that may be linked to Covid-19 vaccines after probing pediatric deaths allegedly tied...

FDA General

Experts Call for Overhaul of FDA Revolving Door Rules

Two pharmacist-attorneys (BakerHostetler) urge Congress to strengthen federal restrictions on how senior FDA officials move into private-sector roles,...

latest-news-card-1
Medical Devices

Draeger Recalls Airway Catheter Mount

Draeger recalls (Class 1) its ErgoStar CM 60 (catheter mount 60), an airway connector/catheter mount, after receiving multiple complaints reporting de...

latest-news-card-1
Human Drugs

Prescription to Nonprescription Switch MAPP

CDER issues a Manual of Policies and Procedures for when a reference-listed drug switches from prescription to nonprescription marketing status and AN...

latest-news-card-1
Biologics

Petition Urges FDA to Overhaul Biosimilar Approval Rules

A biosimilars scholar files a citizen petition urging FDA to dramatically streamline and modernize its biosimilar approval requirements.

latest-news-card-1
Biologics

FDA OKs 1st Cellular Therapy for Severe Aplastic Anemia

FDA approves Gamida Cells Omisirge, the first cellular therapy authorized to treat patients with severe aplastic anemia.

latest-news-card-1
Human Drugs

FDA Delays Safety Review of Abortion Pill Mifepristone

FDA postpones a promised safety review of the abortion drug mifepristone and is now not likely to be released until after the 2026 midterm elections.

latest-news-card-1
Human Drugs

BioNTech, OncoC4 See Good Survival Data for Lung Cancer Drug

BioNTech and OncoC4 say their investigational immunotherapy gotistobart significantly extended survival for certain patients with advanced squamous no...

latest-news-card-1
Human Drugs

FDA Delays Decision on Agios Mitapivat sNDA for Thalassemia

FDA delays its review decision on an Agios Pharmaceuticals supplemental NDA for mitapivat, its oral therapy for adults with both transfusion-dependent...

latest-news-card-1
Human Drugs

Dyne Reports Strong Dystrophin Gains in Duchenne Study

Dyne Therapeutics reports positive topline results from its Phase 1/2 DELIVER trial of z-rostudirsen (DYNE-251), saying the investigational exon-skipp...